The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Clinical Benefits of Early Triptan Therapy for Migraine
Abstract
The introduction of the triptans brought advances in achieving complete and sustained pain resolution in migraine patients, compared with non-migraine-specific treatments. However, sustained pain-free rates for triptans recorded in many clinical trials are still relatively low. This may be due to study participants being treated late into the attack, when pain is already moderate or severe. Studies with almotriptan have shown that efficacy is enhanced when treatment is given early in a migraine attack while pain is still mild, compared with later administration when pain intensity is greater. Developments in our understanding of migraine pathophysiology provide a rationale for this phenomenon, with improved efficacy seen when abortive treatment is administered before central sensitization develops. A limited window of therapeutic opportunity exists early in an attack to improve the outcome of triptan treatment. Early intervention is recommended to avoid the significant pain and disability commonly associated with moderate or severe migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Cited by
Scrivani, S. J., Keith, D. A., & Kaban, L. B. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802472 · Cited by 739
Amin, F. M., Hougaard, A., Schytz, H. W., Asghar, M. S., Lundholm, E., Parvaiz, A. I., de Koning, P. J. H., Andersen, M. R., Larsson, H. B. W., Fahrenkrug, J., et al. (2014) · Brain · doi:10.1093/brain/awt369 · Cited by 262
de Tommaso, M., Nolano, M., Iannone, F., Vecchio, E., Ricci, K., Lorenzo, M., Delussi, M., Girolamo, F., Lavolpe, V., Provitera, V., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7211-9 · Cited by 73
Metadata
- Authors
- Láinez, M.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 2004-11
- Volume
- 24
- Issue
- 2_suppl
- Pages
- 24-30
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2170096433
- Cited by
- 181
- References
- 2
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Benefits of Early Triptan Therapy for Migraine. https://app.cochat.ai/papers/10.1111/j.1468-2982.2004.00895.x
- The paper
- Láinez, M. (2004). Clinical Benefits of Early Triptan Therapy for Migraine. Cephalalgia. https://doi.org/10.1111/j.1468-2982.2004.00895.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.